Aims: Hepatic progenitor cells (HPCs) are activated in various liver diseases, but their role in the carcinomatous environment remains unknown. We aimed to identify the possible presence and topography of HPCs in liver metastases. Methods and results: We examined 14 liver resection specimens for colorectal adenocarcinoma (n = 13) and anal squamous cell carcinoma (n = 1) metastases. Immunohistochemical markers of colonic origin (keratin 20 and CDX2) and squamous cell origin (p63), HPC [keratin 19 (K19) and CD56] and stem cell (CD44) markers, and the biliary marker keratin 7 (K7), which may also highlight HPCs, were applied on routinely processed tissue sections. Double immunohistochemistry/immunofluorescence (K7/ CDX2) and confocal microscopy were used on selected sections. K7-positive, Κ19-positive and CD56-positive ductular structures were encountered within the metastatic tumour (tumour interior and periphery), and in the immediate peritumoral area. Hybrid structures composed of HPCs and metastatic adenocarcinoma cells were recognised and confirmed by double immunostaining (K7/CDX2). Carcinoma cells were also observed singly or in groups within the epithelium of interlobular bile ducts and/or ductules in portal tracts without evidence of carcinomatous infiltration and at a distance from the metastatic foci. Conclusions: HPCs are observed at the periphery and in the interior of liver metastatic carcinomas. Bile ductules and small interlobular bile ducts may attract carcinoma cells serving as a potential 'metastatic niche', in line with their recognised role as HPC niches in non-neoplastic liver.
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Introduction
The hepatic progenitor cell (HPC) compartment comprises a spectrum of subtypes of variable differentiation, including isolated progenitor cells and string-like ductular structures (DSs) at the portal-parenchymal interface known as ductular reaction.
1,2 Intermediate hepatocytes, keratin 7 (K7)-positive hepatocytes and bile ductules are more differentiated forms of increasing maturity. The HPC immunophenotype includes hepatocytic, cholangiocellular, hepatoblast and haematopoietic stem cell markers. [3] [4] [5] [6] There are sufficient data to suggest that adult HPCs may also derive from mature hepatocytes through a dedifferentiation process in the context of acute and chronic liver injury. [7] [8] [9] Hepatocyte loss in association with impaired hepatocyte regenerative capacity, replicative exhaustion and senescence are triggering factors for an alternative regeneration pathway involving HPCs. 1, 5, 7 In contrast, the functional role of HPCs in primary and metastatic liver carcinoma remains unknown. We aimed to explore the presence and topography of HPCs in metastatic liver carcinomas.
Patients and methods
The presence of HPCs was examined in 13 specimens of liver metastasectomies (segmental hepatectomies, n = 10; left hepatectomies, n = 2; right hepatectomy, n = 1) for colorectal adenocarcinoma (CRC) and a metachronous solitary liver metastasis of anal squamous cell carcinoma (SCC), which was removed by segmental hepatectomy.
Metastatic adenocarcinomas were selected from a total of 60 cases of liver CRC metastasis resected between 2007 and 2014, according to the following inclusion criteria: (i) metastatic CRC excised concurrently with the resection of the primary tumour; (ii) no preoperative neoadjuvant chemotherapy; and (iii) primary CRC immunophenotype different from that of HPC, biliary epithelial cells, and hepatocytes [CDX2/ keratin 20 (K20)-positive and K7/CD56/HepPar-1-negative]. All primary carcinomas and their metastatic foci were of moderate histological differentiation, and four showed extensive necrosis. Informed consent for the use of surplus diagnostic material for research purposes was obtained from each patient prior to surgery. The study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki.
Immunohistochemical examination of serial paraffin sections included stains for K20 and CDX2 (CRC markers), keratin 19 (K19) and CD56 (HPC markers), CD44 (stem cell marker), and K7 (biliary marker that also highlights HPCs). In the metastatic anal SCC, p63 was used as a nuclear marker for the identification of SCC tumour cells. Double immunostaining was performed with K7 and CDX2 in CRC metastases. Additionally, double immunofluorescence for K7 and CDX2 was performed in selected sections evaluated by confocal microscopy. K19 was not used as an HPC marker in the double immunostaining experiments, because it may be expressed by CRC cells.
The presence of HPC subtypes was examined within the metastatic tumour (tumour interior and periphery), in the immediate peritumoral area (one low-power field 910), and in the adjacent non-neoplastic liver tissue (the tumour periphery and peritumoral area are depicted in Figure S1 ). One representative section from each case was examined, and the density of HPC subtypes was assessed semiquantitatively. Ductular reaction at the portalparenchymal interface of non-neoplastic liver tissue was recorded.
Details of antibodies and methodology are given in File S1.
Results
In all cases, variable numbers of K7-positive and CD56-positive DSs and mature ductules were encountered in the immediate peritumoral area, whereas ductular reaction constituted a rather common finding in the neighbouring non-neoplastic liver. DSs were also discernible at the periphery and, less frequently, in the interior of carcinomatous foci, both in the stroma and in the epithelial component ( Figure 1A ). K20, CDX2 and p63 were negative in DSs. In contrast, carcinoma cells did not show HPC markers, and were immunostained diffusely for K20 and CDX2 in metastatic CRC foci and for p63 in metastatic SCC. CD44-positive cells were rarely encountered. HepPar-1-positive hepatocytes were visible, usually in small groups, in the peritumoral stroma, whereas only a few entrapped atrophic HepPar-1-positive hepatocytes were still visible at the tumour periphery.
In all metastatic CRC cases, examination of immunostained serial sections at high magnification revealed HPCs adherent to carcinoma cells, creating hybrid structures of combined HPC-carcinomatous composition. This phenomenon was evident from the differences in cell morphology and immunophenotype between HPCs and carcinoma cells ( Figure 1B-D) . HPCs were small-sized and flat with oval nuclei without atypia, whereas the carcinoma cells were larger, cuboidal or cylindrical with atypical nuclei. HPCs showed a typical immunohistochemical profile (K7/CD56-positive and K20/CDX2-negative), in contrast to carcinoma cells, which stained positively only for CRC markers (K20 and CDX2) or p63. Immunohistochemical investigation also revealed solitary HPCs among carcinoma cells.
The aforementioned observations were confirmed by double K7/CDX2 immunofluorescence assessed by confocal microscopy (Figure 1E ,F; Figure S2 ) and double K7/CDX2 immunostaining ( Figure S3 ) that highlighted the dual nature of the hybrid tubular structures and the structural coexistence of the different cell types. No cells coexpressing K7/CDX2 were identified.
In the single anal SCC metastasis case, intratumoral HPCs were encountered as isolated cells within carcinoma sheets, recognised by their typical immunoprofile in contrast to p63-positive anal SCC cells.
In six CRC cases and in the anal SCC case, K20-positive and p63-positive carcinoma cells, singly or in small groups, were seen in interlobular ducts and ductules located in portal tracts at a distance from the periphery of the tumours (Figure 2 ). There were no signs of invasion of the intervening non-neoplastic liver tissue or the portal tract stroma, or disruption of the basement membrane of the involved ducts and ductules. Table S1 shows detailed immunohistochemical results for each hepatic CRC metastasis case.
Discussion
HPCs show features of stemness, represented by their multilineage differentiation capacity, their ability to migrate, and their involvement in carcinogenesis. 10 Hepatic stem/progenitor cells give rise to carcinomas with stem cell features and their subtypes, 11 and retrodifferentiation of hepatocellular carcinoma (HCC) cells induced in vitro by inflammatory cytokines has been implicated as an additional carcinogenic pathway. 12 In-vitro and in-vivo models in a single study 13 suggested that HPCs may have a marked effect on HCC cells, and appear to stimulate the growth and malignant potential of experimental HCC tumours. With respect to the spatial relationship of HPCs and tumour tissue, oval cells localised inside and outside the carcinomatous foci have been observed in rats, 14 and HPCs have very occasionally been reported in human hepatocellular tumours. 15, 16 Our study is the first to highlight the existence of HPCs within metastatic liver carcinomas, usually in the form of DSs. They were encountered in the newly formed peritumoral and intratumoral stroma, as well as within the carcinomatous epithelial component. The most impressive finding was their presence in hybrid tubular structures of mixed HPC/carcinoma cell composition. The detection of HPCs was facilitated by their specific morphology and immunoprofile in combination with the absence of the CRC cell markers K20 and CDX2 and the SCC marker p63, and was confirmed by double immunostaining (K7 and CDX2) and double immunofluorescence (K7 and CDX2). Various hypotheses may explain this phenomenon. Activation of HPCs originating from entrapped non-neoplastic ductules and small ducts or HPC migration into the metastatic foci under the influence of chemoattractants are plausible explanations. Regarding the hybrid structures, they may represent the end-product of DS contact with carcinomatous elements by creating new HPC-carcinoma cell adhesions or may derive from DS infiltration by carcinoma cells.
Another unique observation was the detection of carcinoma cells singly or in groups within interlobular bile ducts and/or ductules at a distance from the main tumour mass in the absence of portal tract invasion. Colonisation of major and minor bile ducts and intrabiliary growth has long been recognised. 17, 18 However, it has not been clarified whether this phenomenon may be attributable to bile duct invasion from a parenchymal metastatic focus or whether it represents a genuine intrabiliary metastasis. The presence of single carcinoma cells within the ductular epithelium is indicative of a metastatic process.
What seems to be undisputable in our study is the occasional symbiosis of benign HPCs and biliary epithelial cells with malignant cells in metastatic liver carcinomas. This phenomenon can be ascribed to the stem cell properties shared by HPCs and possible cancer stem cells. Being endowed with growth factors and cytokines (e.g. lymphotoxin-b, monocyte chemoattractant protein-1, platelet-derived growth factor, and transforming growth factor-b), [19] [20] [21] [22] [23] HPCs participate in fibrogenesis and liver cell regeneration, and may potentially contribute to tumour growth and stroma formation, adopting a role similar to that of bone marrow stem cells in the expansion of primary and metastatic carcinomas. 24 On the other hand, it is reasonable to assume that cytokines, growth factors and chemokines produced by tumour stroma and carcinoma cells may activate and attract HPCs. It is well known that HPCs require essential proinflammatory cytokines and growth factors, analogous to those produced by carcinoma cells, to proliferate and differentiate. 25 Finally, the colonisation of small bile ducts and ductules by carcinoma cells highlights a potential metastatic niche that already functions as a suitable microenvironment for nonneoplastic HPCs.
Limitations of our study include the small, although representative, number of cases, and the examination of only two types of metastatic liver cancer in the context of an observational study. It may be argued that the individual immunohistochemical markers used to support or exclude CRC, SCC or HPC origin are not 100% specific or sensitive. However, when these markers are jointly assessed in conjunction with careful morphological examination, their application is appropriate for the purpose of our study.
In conclusion, our morphological and immunohistochemical study provides strong indications of HPC presence within metastatic liver carcinomas, usually in the form of immature DSs. Bile ductules and small 
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